{"id":30510,"date":"2022-01-21T15:29:35","date_gmt":"2022-01-21T13:29:35","guid":{"rendered":"https:\/\/aluksne.lv\/?p=30510"},"modified":"2022-01-21T16:05:47","modified_gmt":"2022-01-21T14:05:47","slug":"vakcinacijas-sertifikata-deriguma-termins-no-15-februara","status":"publish","type":"post","link":"https:\/\/aluksne.lv\/index.php\/2022\/01\/21\/vakcinacijas-sertifikata-deriguma-termins-no-15-februara\/","title":{"rendered":"Vakcin\u0101cijas sertifik\u0101ta der\u012bguma termi\u0146\u0161 \u2013 no 15. febru\u0101ra"},"content":{"rendered":"

\"Vakcin\u0101cijasSVAR\u012aGI zin\u0101t!<\/strong><\/p>\n

\u00a0<\/strong><\/p>\n

Covid-19 omikrona varianta strauj\u0101s izplat\u012bbas d\u0113\u013c, lai mazin\u0101tu infekcijas izplat\u012bbu, Latvij\u0101 noteikts PRIM\u0100R\u0100S VAKCIN\u0100CIJAS SERTIFIK\u0100TA DER\u012aGUMA TERMI\u0145\u0160.<\/strong><\/p>\n

 <\/p>\n

Nosac\u012bjums par prim\u0101r\u0101s vakcin\u0101cijas sertifik\u0101tu der\u012bguma termi\u0146u Latvij\u0101 st\u0101sies sp\u0113k\u0101 15. febru\u0101r\u012b. Tas netiks attiecin\u0101ts uz person\u0101m l\u012bdz 18 gadiem, jo \u0161ai iedz\u012bvot\u0101ju grupai balstvakcin\u0101cija pa\u0161laik nav nepiecie\u0161ama.<\/p>\n

 <\/p>\n

Vakcin\u0113tajiem cilv\u0113kiem sertifik\u0101ts b\u016bs sp\u0113k\u0101 9 m\u0113ne\u0161us p\u0113c prim\u0101r\u0101s vakcin\u0101cijas kursa pabeig\u0161anas ar\u00a0Vaxzevria, Spikevax, Comirnaty<\/em>\u00a0vakc\u012bn\u0101m un 5 m\u0113ne\u0161us p\u0113c\u00a0Janssen<\/em>\u00a0vakc\u012bnas sa\u0146em\u0161anas.<\/p>\n

 <\/p>\n

\u0160obr\u012bd sertifik\u0101ta der\u012bguma termi\u0146u var apr\u0113\u0137in\u0101t, apskatot sav\u0101 sertifik\u0101t\u0101 nor\u0101d\u012bto datumu, kur\u0101 veikta vakcin\u0101cija. Tas ir j\u0101skaita no n\u0101kam\u0101s dienas p\u0113c otr\u0101s potes sa\u0146em\u0161anas. Nacion\u0101lais vesel\u012bbas dienests pl\u0101no risin\u0101jumu, lai digit\u0101laj\u0101 sertifik\u0101t\u0101 tiktu iek\u013cauta inform\u0101cija, kad katram beidzas sertifik\u0101ta der\u012bguma termi\u0146\u0161.<\/p>\n

 <\/p>\n

Covid-19 vakcin\u0101cijas sertifik\u0101ts ir der\u012bgs uzreiz p\u0113c balstvakcin\u0101cijas veik\u0161anas.<\/p>\n

 <\/p>\n

\u00a0<\/em><\/p>\n

Piesakies balstvakcin\u0101cijai laikus!<\/strong><\/p>\n

Nacion\u0101lais vesel\u012bbas dienests aicina balstvakcin\u0101cijai pieteikties laikus un nenogaid\u012bt \u2013 tas ir \u012bpa\u0161i svar\u012bgi, strauji izplatoties Covid-19 omikrona paveidam.<\/p>\n

 <\/p>\n

Saska\u0146\u0101 ar zin\u0101tniskajiem p\u0113t\u012bjumiem, lai saglab\u0101tu organisma aizsardz\u012bbu pret v\u012brusu un nov\u0113rstu riskus smagas slim\u012bbas gaitai, vajadz\u012bga balstvakcin\u0101cija. P\u0113t\u012bjumi liecina, ka balstvakc\u012bna pieaugu\u0161ajiem b\u016btiski samazina hospitaliz\u0101ciju risku, sniedz aizsardz\u012bbu pret infekciju, un tam ir ietekme ar\u012b uz saslimst\u012bbas mazin\u0101\u0161anu.<\/p>\n

 <\/p>\n

Cilv\u0113ki, kuriem ir veiktas vismaz divas potes, ieg\u016bst 50-70% lielu aizsargefektu pret hospitaliz\u0101ciju. Ja ir veikta\u00a0balstvakcin\u0101cija, tad \u0161is aizsargefekts ir tuvu 90%, kas ir \u013coti b\u016btiski, v\u0113rt\u0113jot slim\u012bbas ietekmi uz sabiedr\u012bbas vesel\u012bbu, uzsver Slim\u012bbu profilakses un kontroles centra speci\u0101listi.<\/p>\n

 <\/p>\n

Nacion\u0101l\u0101 vesel\u012bbas dienesta dati liecina, ka Al\u016bksnes novad\u0101 15. febru\u0101r\u012b prim\u0101r\u0101s vakcin\u0101cijas sertifik\u0101ta der\u012bguma termi\u0146\u0161 beigsies 829 person\u0101m, ja netiks veikta balstvakcin\u0101cija. Balstvakc\u012bnu uz 15.\u00a0febru\u0101ri var sa\u0146emt 6035 Al\u016bksnes novada iedz\u012bvot\u0101ji.<\/p>\n

 <\/p>\n\n\n\n\n
\n

Pa\u0161vald\u012bba<\/strong><\/p>\n<\/td>\n

\n

Var sa\u0146emt balstvakc\u012bnu uz 15. febru\u0101ri (v\u0113l nav sa\u0146\u0113mu\u0161i)<\/strong><\/p>\n<\/td>\n

\n

Beigsies sertifik\u0101ts 15. febru\u0101r\u012b<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

Al\u016bksnes novads<\/p>\n<\/td>\n

\n

6035<\/p>\n<\/td>\n

\n

829<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

P\u0113c Nacion\u0101l\u0101 vesel\u012bbas dienesta datiem Al\u016bksnes novad\u0101 l\u012bdz 14. janv\u0101rim vakcin\u0101ciju ir pabeigu\u0161i 70,80% iedz\u012bvot\u0101ju, valst\u012b kopum\u0101 – 67,41% iedz\u012bvot\u0101ju.<\/p>\n

 <\/p>\n

Balstvakcin\u0101ciju Al\u016bksnes novad\u0101 ir veiku\u0161i 20,97% iedz\u012bvot\u0101ju, valst\u012b kopum\u0101 \u2013 18,15%.<\/p>\n

 <\/p>\n\n\n\n\n\n\n
\n

Teritorija<\/strong><\/p>\n<\/td>\n

\n

PERSONAS, kas pabeigu\u0161as vakcin\u0101ciju (vecuma grupas) \/ Iedz\u012bvot\u0101ju skaits %<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

16-17<\/strong><\/p>\n<\/td>\n

\n

18-29<\/strong><\/p>\n<\/td>\n

\n

30-39<\/strong><\/p>\n<\/td>\n

\n

40-49<\/strong><\/p>\n<\/td>\n

\n

50-59<\/strong><\/p>\n<\/td>\n

\n

60-69<\/strong><\/p>\n<\/td>\n

\n

70-79<\/strong><\/p>\n<\/td>\n

\n

80-89<\/strong><\/p>\n<\/td>\n

\n

>90<\/strong><\/p>\n<\/td>\n

\n

Kop\u0101<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

Al\u016bksnes novads<\/p>\n<\/td>\n

\n

68.24%<\/strong><\/p>\n<\/td>\n

\n

71.59%<\/strong><\/p>\n<\/td>\n

\n

83.80%<\/strong><\/p>\n<\/td>\n

\n

84.01%<\/strong><\/p>\n<\/td>\n

\n

83.26%<\/strong><\/p>\n<\/td>\n

\n

89.47%<\/strong><\/p>\n<\/td>\n

\n

81.02%<\/strong><\/p>\n<\/td>\n

\n

74.64%<\/strong><\/p>\n<\/td>\n

\n

57.34%<\/strong><\/p>\n<\/td>\n

\n

70.80%<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

Valst\u012b kopum\u0101 <\/strong><\/p>\n<\/td>\n

\n

70.38%<\/p>\n<\/td>\n

\n

78.67%<\/p>\n<\/td>\n

\n

80.72%<\/p>\n<\/td>\n

\n

80.04%<\/p>\n<\/td>\n

\n

81.13%<\/p>\n<\/td>\n

\n

80.96%<\/p>\n<\/td>\n

\n

76.29%<\/p>\n<\/td>\n

\n

66.73%<\/p>\n<\/td>\n

\n

45.53%<\/p>\n<\/td>\n

\n

67.41%<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/strong><\/p>\n\n\n\n\n\n\n
\n

Teritorija<\/strong><\/p>\n<\/td>\n

\n

Balstvakcin\u0101ciju skaits (vecuma grupas) \/ Iedz\u012bvot\u0101ju skaits %<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

18-29<\/strong><\/p>\n<\/td>\n

\n

30-39<\/strong><\/p>\n<\/td>\n

\n

40-49<\/strong><\/p>\n<\/td>\n

\n

50-59<\/strong><\/p>\n<\/td>\n

\n

60-69<\/strong><\/p>\n<\/td>\n

\n

70-79<\/strong><\/p>\n<\/td>\n

\n

80-89<\/strong><\/p>\n<\/td>\n

\n

>90<\/strong><\/p>\n<\/td>\n

\n

Kop\u0101<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

Al\u016bksnes novads<\/p>\n<\/td>\n

\n

10.63%<\/strong><\/p>\n<\/td>\n

\n

17.09%<\/strong><\/p>\n<\/td>\n

\n

20.13%<\/strong><\/p>\n<\/td>\n

\n

23.80%<\/strong><\/p>\n<\/td>\n

\n

37.81%<\/strong><\/p>\n<\/td>\n

\n

41.16%<\/strong><\/p>\n<\/td>\n

\n

35.69%<\/strong><\/p>\n<\/td>\n

\n

21.68%<\/strong><\/p>\n<\/td>\n

\n

20.97%<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

Valst\u012b kopum\u0101 <\/strong><\/p>\n<\/td>\n

\n

12.36%<\/p>\n<\/td>\n

\n

16.96%<\/p>\n<\/td>\n

\n

20.35%<\/p>\n<\/td>\n

\n

22.19%<\/p>\n<\/td>\n

\n

28.90%<\/p>\n<\/td>\n

\n

34.65%<\/p>\n<\/td>\n

\n

29.40%<\/p>\n<\/td>\n

\n

16.91%<\/p>\n<\/td>\n

\n

18.15%<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

 <\/p>\n

Kur sa\u0146emt balstvakc\u012bnu<\/strong><\/p>\n

 <\/p>\n

Balstvakc\u012bnu, t\u0101pat k\u0101 prim\u0101ro vakcin\u0101ciju, Al\u016bksnes novad\u0101 var sa\u0146emt:<\/p>\n